Search Results - "Atkins, J N"

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer by Fisher, Bernard, Dignam, James, Emir, Birol, Bryant, John, DeCillis, Arthur, Wolmark, Norman, Wickerham, D. Lawrence, Dimitrov, Nikolay V., Abramson, Neil, Atkins, James N., Shibata, Henry, Deschenes, Luc, Margolese, Richard G.

“…Background: The B-20 study of the National Surgical Adjuvant Breast and Bowel Project (NSABP) was conducted to determine whether chemotherapy plus tamoxifen…”
Get full text

Comparative Efficacy of Adjuvant Chemotherapy in Patients With Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04) by MAMOUNAS, E, WIEOND, S, WOLMARK, N, BEAR, H. D, ATKINS, J. N, KYUNGHEE SONG, JONES, J, ROCKETTE, H

“…Although the benefit from adjuvant chemotherapy has been clearly established in patients with Dukes' C colon cancer, such benefit has been questioned in…”
Get full text

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207 by Rosenberg, J. E., Halabi, S., Sanford, B. L., Himelstein, A. L., Atkins, J. N., Hohl, R. J., Millard, F., Bajorin, D. F., Small, E. J.

“…Background: There is no standard second-line treatment for advanced urothelial carcinoma (UC). Response rates to second-line chemotherapy for advanced UC are…”
Get full text

Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group by Cleeland, C. S., Portenoy, R. K., Rue, M., Mendoza, T. R., Weller, E., Payne, R., Kirshner, J., Atkins, J. N., Johnson, P. A., Marcus, A.

“…Background:: Cancer pain is highly prevalent and commonly undertreated. This study was designed to determine whether dissemination of a clinical protocol for…”
Get full text

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22 by Fisher, B, Anderson, S, Wickerham, D L, DeCillis, A, Dimitrov, N, Mamounas, E, Wolmark, N, Pugh, R, Atkins, J N, Meyers, F J, Abramson, N, Wolter, J, Bornstein, R S, Levy, L, Romond, E H, Caggiano, V, Grimaldi, M, Jochimsen, P, Deckers, P

“…The National Surgical Adjuvant Breast and Bowel Project (NSABP) initiated a randomized trial (B-22) to determine if intensifying but maintaining the total dose…”
Get more information

Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04 by WOLMARK, N, ROCKETTE, H, FISHER, E. R, FISHER, B, MAMOUNAS, E, JONES, J, WIEAND, S, WICKERHAM, D. L, BEAR, H. D, ATKINS, J. N, DIMITROV, N. V, GLASS, A. G

“…To compare the efficacy of leucovorin-modulated fluorouracil (FU+LV) with that of fluorouracil and levamisole (FU+LEV) or with the combination of FU+LV and…”
Get full text

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902 by Rocha-Lima, C.M., Herndon, J.E., Lee, M.E., Atkins, J.N., Mauer, A., Vokes, E., Green, M.R.

“…Background: This phase II study evaluated the efficacy and safety of the irinotecan/gemcitabine combination in patients with relapsed/refractory small-cell…”
Get full text

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil by Fisher, B, Dignam, J, Mamounas, E P, Costantino, J P, Wickerham, D L, Redmond, C, Wolmark, N, Dimitrov, N V, Bowman, D M, Glass, A G, Atkins, J N, Abramson, N, Sutherland, C M, Aron, B S, Margolese, R G

“…To compare sequential methotrexate (M) and fluorouracil (F) (M-->F) with surgery (National Surgical Adjuvant Breast and Bowel Project [NSABP] B-13) and…”
Get more information

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23 by FISHER, Bernard, ANDERSON, Stewart, ROMOND, Edward H, KARDINAL, Carl G, SHIBATA, Henry R, MARGOLESE, Richard G, FARRAR, William B, TAN-CHIU, Elizabeth, WOLMARK, Norman, WICKERHAM, D. Lawrence, FISHER, Edwin R, DIMITROV, Nikolay V, ATKINS, James N, ABRAMSON, Neil, MERAJVER, Sofia

“…Uncertainty about the relative worth of doxorubicin/cyclophosphamide (AC) and cyclophosphamide/methotrexate/fluorouracil (CMF), as well as doubt about the…”
Get full text

Further Evaluation of Intensified and Increased Total Dose of Cyclophosphamide for the Treatment of Primary Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-25 by FISHER, B, ANDERSON, S, KARDINAL, C. G, LAUFMAN, L, PIERCE, H. I, ABRAMSON, N, KELLER, A. M, HAMM, J. T, WICKERHAM, D. L, BEGOVIC, M, TAN-CHIU, E, WEI TIAN, DECILLIS, A, WOLMARK, N, DIMITROV, N, ATKINS, J. N, FEHRENBACHER, L, HENRY, P. H, ROMOND, E. H, LANIER, K. S, DAVILA, E

“…In 1989, the National Surgical Adjuvant Breast and Bowel Project initiated the B-22 trial to determine whether intensifying or intensifying and increasing the…”
Get full text

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532 by Perry, Michael C, Ihde, Daniel C, Herndon II, James E, Grossbard, Michael L, Grethein, Sara J, Atkins, James N, Vokes, Everett E, Green, Mark R

“…In order to explore non-cisplatin containing regimens for advanced non-small cell lung cancer, Cancer and Leukemia Group B conducted a randomized Phase-II…”
Get full text

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study by Muss, H B, Case, L D, Atkins, J N, Bearden, 3rd, J D, Cooper, M R, Cruz, J M, Jackson, Jr, D V, O'Rourke, M A, Pavy, M D, Powell, B L

“…To determine in a prospective randomized trial whether high-dose orally administered medroxy-progesterone acetate (MPA) was superior to tamoxifen in patients…”
Get more information

Amelioration of vincristine neurotoxicity by glutamic acid by Jackson, D V, Wells, H B, Atkins, J N, Zekan, P J, White, D R, Richards, 2nd, F, Cruz, J M, Muss, H B

“…Neurotoxicity is the principal limiting side effect of the widely used antitumor agent, vincristine. Following evaluation of glutamic acid as a potential…”
Get more information

Recruiting cancer patients to participate in motivating their relatives to quit smoking : A cancer control study of the Cancer and Leukemia Group B (CALGB 9072) by SCHILLING, A, CONAWAY, M. R, WINGATE, P. J, ATKINS, J. N, BERKOWITZ, I. M, CLAMON, G. H, DIFINO, S. M, VINCIGUERRA, V

“…A diagnosis of cancer provides a teachable moment in which a physician can counsel or teach the patient. The Cancer and Leukemia Group B hypothesized that this…”
Get full text

Leucovorin and high-dose fluorouracil in metastatic prostate cancer : a phase II trial of the Piedmont oncology association by ATKINS, J. N, MUSS, H. B, CASE, L. D, RICHARDS, F. II, GROTE, T, MCFARLAND, J

“…We performed a Phase II trial of oral leucovorin and high-dose fluorouracil (5FU) in hormone refractory patients with metastatic prostate cancer who had not…”
Get full text

Fluorouracil and the palmar-plantar erythrodysesthesia syndrome by Atkins, J N

Get more information

High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association by Atkins, J N, Muss, H B, Case, D, Brockschmidt, J, Schnell, F M, O'Rourke, M, Grote, T H, West, J H, Anthony, S, Stanley, V

“…Thirty-two patients with metastatic carcinoma of the prostate refractory to endocrine therapy were entered on trial. No patient entered in the study had prior…”
Get more information

Platelet-aggregating factor in thrombotic thrombocytopenic purpura by Atkins, J N

Get more information

PCA pump by Atkins, J N

Get more information

A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study by White, D R, Powell, B L, Craig, J B, Stuart, R K, Schnell, F M, Goldklang, G A, Atkins, J N, Jackson, D V, Richards, 2nd, F, Muss, H B

“…Thirty-seven chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) were treated with cytarabine (3 g/m2 intravenously [IV] during 3…”
Get more information